Abstract
Patients with diffuse pontine gliomas have a median survival of less than one year and represent a challenge for pediatric oncologists, prompting them to attempt experimental therapies. From 1987 to 2005, 62 children with diffuse pontine glioma, not amenable to curative surgery, were treated according to four successive pilot protocols: (1) concomitant chemo–radiotherapy (etoposide, cytarabine, ifosfamide, cisplatin, and dactinomycin); (2) intensive high-dose courses chemotherapy (cisplatin/etoposide, cyclophosphamide/vincristine/methotrexate) and a subsequent course of myeloablative thiotepa followed by radiation and maintenance chemotherapy; (3) cisplatin/etoposide followed by isotretinoin before, during and after focal irradiation; and (4) iv vinorelbine before, during, and after irradiation. Considering all patients, 77% experienced a transient response to treatment, always detectable after radiotherapy. The progression-free survival (PFS) rate was 25 ± 6% at one year, median PFS was seven months; overall survival (OS) was 45 ± 6%, median OS was eleven months: no statistical differences in the four studies in terms of outcome were detected. Despite improved diagnostic, therapeutic, and supportive tools in pediatric neuro-oncology, little has been achieved for patients with diffuse pontine tumors.
Similar content being viewed by others
References
Albright AL, Packer RJ, Zimmerman R et al (1999) Magnetic resonance scan should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33:1026–1029
Shiminski-Maher T, Abbot R, Wisoff JH, Epstein FJ (1991) Current trends in the management of brainstem tumors in childhood. J Neurosci Nurs 23:356–362
Benesch M, Lackner H, Moser A et al (2001) Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas. Pediatr Neurosurg 35:173–180
Korones DN (2007) Treatment of newly diagnosed diffuse brain stem gliomas in children: in search of the holy grail. Expert Rev Anticancer Ther 7:663–674
Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248
Massimino M, Gandola L, Casanova M et al (2000) Concomitant chemoradiotherapy for childhood poor-prognosis gliomas. Med Pediatr Oncol 34:147–150
Massimino M, Gandola L, Luksch R et al (2005) Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma. Neuro Oncol 7:41–48
Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457–481
Peto R, Peto J (1972) Asymptomatically efficient rank invariant test procedures. J R Stat Soc [A] 135:185–207
Massimino M, Simonetti F, Balestrini MR, Spreafico F et al (2006) Transitory, spontaneously recovering, peripheral facial nerve palsy after vinorelbine administration. Neurol Sci 27:110–113
Langmoen IA, Lundar T, Storm-Mathisen I et al (1991) Management of pediatric pontine gliomas. Childs Nerv Syst 7:13–15
Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24:1266–1272
Mandell LR, Kadota R, Freeman C et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brain stem tumors: results of a pediatric oncology group phase III trial comparing conventional vs hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959–964
Doz F, Neuenschwander S, Bouffet E et al (2002) Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d’Oncologie Pédiatrique. Eur J Cancer 38:815–819
Schwaofer JH, Crooijmans RP, Hoogenhout J, Kal HB, Theeuwes AG (1991) Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol Biol Phys 20:1235–1241
Freeman CR, Kepner J, Kun LE et al (2000) A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int J Radiat Oncol Biol Phys 47:561–564
Dunkel IJ, O’Malley B, Finlay JL (1996) Is there a role for high-dose chemotherapy with stem cell rescue for brain stem tumors of childhood? Pediatr Neurosurg 24:263–266
Bouffet E, Raquin M, Doz F et al (2000) Radiotherapy followed by high dose busulfan and thiotepa. A prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88:685–692
Massimino M, Spreafico F, Cefalo G et al (2002) High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209–4216
Kretschmar CS, Tarbell N, Barnes P et al (1993) Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. Cancer 72:1404–1413
Bouterfa H, Picht T, Kess D et al (2000) Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines. Neurosurgery 46:419–430
Yung WKA, Kyritsis AP, Gleason MJ et al (1996) Treatment of recurrent malignant gliomas with high dose 12-cis-retinoic acid. Clin Cancer Res 2:1031–1935
Puduvalli VK, Saito Y, Xu R et al (1999) Fenretinide activates caspases and induces apoptosis in gliomas. Clin Cancer Res 5:2230–2235
Hanley ML, Elion GB, Colvin OM et al (1998) Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors. Cancer Chemother Pharmacol 42:479–482
Binet S, Fellous A, Lataste H et al (1989) In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence. Semin Oncol 16(Suppl 4):5–8
Curran WJ (2002) New chemotherapeutic agents: update of major chemoradiation trials in solid tumors. Oncology 63(Suppl 2):29–38
Biassoni V, Casanova M, Spreafico F, Gandola L, Massimino M (2006) A case of relapsing glioblastoma multiforme responding to vinorelbine. J Neurooncol 80:195–201
Wagner S, Warmuth-Metz M, Emser A et al (2006) Treatment options in childhood pontine gliomas. J Neurooncol 79:281–287
Kornreich L, Schwarz M, Karmazyn B et al (2005) Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature Pediatr Radiol 35:872–879
Gilbertson RJ, Hill DA, Hernan R (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem gliomas. Clin Cancer Res 9:3620–3624
Bode U, Buchen S, Warmuth-Metz M, Pietsch T, Bach F, Fleischhack G (2007) Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings; (abstract) 25, 18S (June 20 Supplement)
Acknowledgements
The authors are indebted to the Associazione “Bianca Garavaglia”, Busto Arsizio, Milano, for partial financial support (scholarships).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Massimino, M., Spreafico, F., Biassoni, V. et al. Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87, 355–361 (2008). https://doi.org/10.1007/s11060-008-9525-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-008-9525-5